As Medicare’s years-long drug-price negotiation process is being hotly debated and litigated, some states are plowing ahead with wide-ranging efforts to bring down costs for a potentially much broader set of prescription drugs.
Medicare this week announced that the first 10 drugs have been selected for negotiation of prices to take effect in 2026, advancing a process that is already the subject of at least eight lawsuits filed by drugmakers and industry groups. But weeks earlier, Colorado beat Medicare to the punch, unveiling…
Read the full article here